Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

INMB

INmune Bio (INMB)

INmune Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INMB
DateTimeSourceHeadlineSymbolCompany
18/09/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
17/09/202410:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
17/09/202400:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
17/09/202400:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INMBINmune Bio Inc
04/09/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
10/08/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
10/08/202406:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INMBINmune Bio Inc
08/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMBINmune Bio Inc
03/08/202406:01Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:INMBINmune Bio Inc
03/08/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
02/08/202406:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMBINmune Bio Inc
31/07/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
20/07/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
14/06/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
13/06/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
31/05/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
30/05/202422:00GlobeNewswire Inc.INmune Bio Inc. to Join Russell 3000® IndexNASDAQ:INMBINmune Bio Inc
30/05/202406:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMBINmune Bio Inc
24/05/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
17/05/202406:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
17/05/202406:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
17/05/202406:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
17/05/202406:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
17/05/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMBINmune Bio Inc
17/05/202406:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMBINmune Bio Inc
10/05/202406:05GlobeNewswire Inc.INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business UpdateNASDAQ:INMBINmune Bio Inc
07/05/202422:00GlobeNewswire Inc.INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9NASDAQ:INMBINmune Bio Inc
30/04/202422:00GlobeNewswire Inc.INmune Bio Inc. Provides Update on Two Patients from the Phase 1b Alzheimer’s Disease Trial who Continue to Receive XPro™ Under Compassionate Use for Over Three YearsNASDAQ:INMBINmune Bio Inc
29/04/202422:00GlobeNewswire Inc.INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune™ Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate CancerNASDAQ:INMBINmune Bio Inc
25/04/202423:00GlobeNewswire Inc.INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:INMBINmune Bio Inc
 Showing the most relevant articles for your search:NASDAQ:INMB